6857:TSEAdvantest Corp. Analysis
Data as of 2026-06-19 - not real-time
¥31,220.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Advantest Corp (6857.T) is trading at ¥31,220, comfortably above its 20‑day (¥27,435) and 50‑day (¥27,395) SMAs and well above the 200‑day SMA (¥21,963), confirming a strong bullish trend. The RSI sits at 64.4, indicating continued momentum without being overbought, while a bullish MACD (line ¥862.99 vs signal ¥333.92) adds technical confirmation. Volatility is elevated at 63.8% over the past 30 days, but the beta is essentially neutral, suggesting price swings are driven more by company‑specific factors than market movements. Fundamentals show robust revenue growth of 41.2% and high profitability (gross margin 64.3%, operating margin 46.7%, ROE 57.6%), yet valuation metrics are stretched: a trailing P/E of 60.9 versus an industry average of 38.1, a P/B of 28.5, and a DCF‑derived fair value of ¥12,411, implying the stock is significantly overvalued at current levels. The dividend is modest (0.2% yield) with a low payout ratio (11.5%) and ample cash balances, supporting dividend sustainability. Recent news highlights Advantest’s #1 global ranking in assembly test equipment and the launch of its Velocity™ automation platform, underscoring competitive leadership and potential upside in data‑center testing.
Given the blend of strong growth fundamentals, premium valuation, and heightened short‑term volatility, the stock is best approached with a cautious stance: hold for the near term while monitoring price action toward the ¥32,000 resistance, and consider buying on pull‑backs if the market re‑prices the growth premium.
Given the blend of strong growth fundamentals, premium valuation, and heightened short‑term volatility, the stock is best approached with a cautious stance: hold for the near term while monitoring price action toward the ¥32,000 resistance, and consider buying on pull‑backs if the market re‑prices the growth premium.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price near the ¥32,000 resistance level
- Elevated 30‑day volatility (63.8%)
- Technical momentum still bullish (MACD, SMA positioning)
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth (41.2%) and high operating margins
- Leadership position confirmed by recent customer‑satisfaction ranking
- Potential upside toward analyst median target of ¥35,000
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustained dividend with low payout ratio
- Continued innovation (Velocity™ platform) supporting market share
- Valuation remains premium, limiting upside without a re‑rating
Key Metrics & Analysis
Financial Health
Revenue Growth41.20%
Profit Margin33.26%
P/E Ratio60.9
ROE57.65%
ROA30.79%
Debt/Equity2.54
P/B Ratio28.5
Op. Cash Flow¥335.2B
Free Cash Flow¥240.9B
Industry P/E38.1
Technical Analysis
TrendBullish
RSI64.4
Support¥24,150.00
Resistance¥32,000.00
MA 20¥27,435.00
MA 50¥27,394.80
MA 200¥21,962.93
MACDBullish
VolumeStable
Fear & Greed Index92.14
Valuation
Fair Value¥12,410.86
Target Price¥33,945.00
Upside/Downside8.73%
GradeOvervalued
TypeGrowth
Dividend Yield0.20%
Risk Assessment
Beta-0.01
Volatility63.76%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.